Camilla Zuckero | Vice President, Investor Relations and Corporate Affairs |
Derek Maetzold | Founder, President and Chief Executive Officer |
Frank Stokes | Chief Financial Officer |
Sung Ji Nam | Scotiabank |
Thomas Flaten | Lake Street |
Good afternoon, and welcome to Castle Biosciences Fourth Quarter 2022 Conference Call.
As a reminder, today's call is being recorded.
We will begin today's call with opening remarks and introductions, followed by a question-and-answer session.
I would like to turn the call over to Camilla Zuckero, Vice President, Investor Relations and Corporate Affairs. Please go ahead.